vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and COHEN & STEERS, INC. (CNS). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $143.8M, roughly 1.6× COHEN & STEERS, INC.). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs -35.0%, a 59.3% gap on every dollar of revenue. On growth, COHEN & STEERS, INC. posted the faster year-over-year revenue change (2.9% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $-126.4M). Over the past eight quarters, COHEN & STEERS, INC.'s revenue compounded faster (8.3% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.
CCRN vs CNS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $236.8M | $143.8M |
| Net Profit | $-82.9M | $34.9M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | 28.0% |
| Net Margin | -35.0% | 24.3% |
| Revenue YoY | -23.6% | 2.9% |
| Net Profit YoY | -2109.7% | -23.9% |
| EPS (diluted) | $-2.56 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $143.8M | ||
| Q3 25 | $250.1M | $141.7M | ||
| Q2 25 | $274.1M | $136.1M | ||
| Q1 25 | $293.4M | $134.5M | ||
| Q4 24 | $309.9M | $139.8M | ||
| Q3 24 | $315.1M | $133.2M | ||
| Q2 24 | $339.8M | $121.7M | ||
| Q1 24 | $379.2M | $122.7M |
| Q4 25 | $-82.9M | $34.9M | ||
| Q3 25 | $-4.8M | $41.7M | ||
| Q2 25 | $-6.7M | $36.8M | ||
| Q1 25 | $-490.0K | $39.8M | ||
| Q4 24 | $-3.8M | $45.8M | ||
| Q3 24 | $2.6M | $39.7M | ||
| Q2 24 | $-16.1M | $31.8M | ||
| Q1 24 | $2.7M | $34.0M |
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 20.4% | — |
| Q4 25 | -30.2% | 28.0% | ||
| Q3 25 | -2.4% | 34.5% | ||
| Q2 25 | -2.1% | 31.8% | ||
| Q1 25 | -0.3% | 33.6% | ||
| Q4 24 | -1.1% | 35.3% | ||
| Q3 24 | 0.9% | 33.7% | ||
| Q2 24 | -5.7% | 31.5% | ||
| Q1 24 | 0.8% | 32.8% |
| Q4 25 | -35.0% | 24.3% | ||
| Q3 25 | -1.9% | 29.4% | ||
| Q2 25 | -2.4% | 27.1% | ||
| Q1 25 | -0.2% | 29.6% | ||
| Q4 24 | -1.2% | 32.8% | ||
| Q3 24 | 0.8% | 29.8% | ||
| Q2 24 | -4.7% | 26.1% | ||
| Q1 24 | 0.7% | 27.7% |
| Q4 25 | $-2.56 | $0.67 | ||
| Q3 25 | $-0.15 | $0.81 | ||
| Q2 25 | $-0.20 | $0.72 | ||
| Q1 25 | $-0.02 | $0.77 | ||
| Q4 24 | $-0.13 | $0.89 | ||
| Q3 24 | $0.08 | $0.77 | ||
| Q2 24 | $-0.47 | $0.63 | ||
| Q1 24 | $0.08 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $145.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $562.0M |
| Total Assets | $449.0M | $876.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $145.5M | ||
| Q3 25 | $99.1M | $98.1M | ||
| Q2 25 | $81.2M | $95.4M | ||
| Q1 25 | $80.7M | $65.2M | ||
| Q4 24 | $81.6M | $183.0M | ||
| Q3 24 | $64.0M | $106.5M | ||
| Q2 24 | $69.6M | $122.0M | ||
| Q1 24 | $5.2M | $99.5M |
| Q4 25 | $322.8M | $562.0M | ||
| Q3 25 | $408.1M | $550.3M | ||
| Q2 25 | $412.2M | $528.5M | ||
| Q1 25 | $418.2M | $507.7M | ||
| Q4 24 | $419.0M | $511.7M | ||
| Q3 24 | $424.7M | $491.0M | ||
| Q2 24 | $433.3M | $463.2M | ||
| Q1 24 | $462.4M | $378.9M |
| Q4 25 | $449.0M | $876.7M | ||
| Q3 25 | $538.2M | $801.6M | ||
| Q2 25 | $553.8M | $751.0M | ||
| Q1 25 | $576.2M | $834.9M | ||
| Q4 24 | $589.3M | $812.4M | ||
| Q3 24 | $597.4M | $727.8M | ||
| Q2 24 | $602.9M | $784.1M | ||
| Q1 24 | $648.4M | $680.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $-120.4M |
| Free Cash FlowOCF − Capex | $16.1M | $-126.4M |
| FCF MarginFCF / Revenue | 6.8% | -87.9% |
| Capex IntensityCapex / Revenue | 0.9% | 4.2% |
| Cash ConversionOCF / Net Profit | — | -3.45× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $-253.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $-120.4M | ||
| Q3 25 | $20.1M | $55.1M | ||
| Q2 25 | $4.2M | $-67.6M | ||
| Q1 25 | $5.7M | $-108.9M | ||
| Q4 24 | $24.2M | $96.7M | ||
| Q3 24 | $7.5M | $25.6M | ||
| Q2 24 | $82.4M | $31.4M | ||
| Q1 24 | $6.0M | $4.9M |
| Q4 25 | $16.1M | $-126.4M | ||
| Q3 25 | $17.9M | $52.6M | ||
| Q2 25 | $2.3M | $-69.8M | ||
| Q1 25 | $3.8M | $-110.0M | ||
| Q4 24 | $21.7M | $85.0M | ||
| Q3 24 | $6.3M | $24.2M | ||
| Q2 24 | $79.6M | $27.1M | ||
| Q1 24 | $3.8M | $537.0K |
| Q4 25 | 6.8% | -87.9% | ||
| Q3 25 | 7.2% | 37.1% | ||
| Q2 25 | 0.8% | -51.3% | ||
| Q1 25 | 1.3% | -81.8% | ||
| Q4 24 | 7.0% | 60.8% | ||
| Q3 24 | 2.0% | 18.2% | ||
| Q2 24 | 23.4% | 22.3% | ||
| Q1 24 | 1.0% | 0.4% |
| Q4 25 | 0.9% | 4.2% | ||
| Q3 25 | 0.9% | 1.8% | ||
| Q2 25 | 0.7% | 1.6% | ||
| Q1 25 | 0.6% | 0.8% | ||
| Q4 24 | 0.8% | 8.3% | ||
| Q3 24 | 0.4% | 1.1% | ||
| Q2 24 | 0.8% | 3.5% | ||
| Q1 24 | 0.6% | 3.5% |
| Q4 25 | — | -3.45× | ||
| Q3 25 | — | 1.32× | ||
| Q2 25 | — | -1.84× | ||
| Q1 25 | — | -2.74× | ||
| Q4 24 | — | 2.11× | ||
| Q3 24 | 2.92× | 0.65× | ||
| Q2 24 | — | 0.99× | ||
| Q1 24 | 2.23× | 0.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
CNS
Segment breakdown not available.